- GE Healthcare IPO this year ‘looks unlikely’ after Danaher deal, CEO Culp says CNBC
- GE to sell BioPharma business to Danaher for $21.4B Fox Business
- GE to Sell Its Biotech Business to Danaher for $21 Billion The Wall Street Journal
- GE shares surge 13% after Danaher agrees to buy biopharma business for $21.4 billion CNBC
- GE’s stock soars after deal to sell biopharma business to Danaher for $21.4 billion MarketWatch
- View full coverage on Google News
Source:: Tech News By Google News